Literature DB >> 17318229

Nucleophosmin acts as a novel AP2alpha-binding transcriptional corepressor during cell differentiation.

Hsuan Liu1, Bertrand Chin-Ming Tan, Kai Hung Tseng, Ching Ping Chuang, Chun-Wei Yeh, Kwang-Den Chen, Sheng-Chung Lee, Benjamin Yat-Ming Yung.   

Abstract

Nucleophosmin (NPM) is an important nucleolar phosphoprotein with pleiotropic functions in various cellular processes. In this study, we have further examined the largely uncharacterized role of NPM in transcriptional regulation by uncovering novel NPM-binding transcriptional factors. Among potential interactors, we found that activating protein transcription factor 2 (AP2)alpha forms a complex with NPM during retinoic-acid-induced cell differentiation. We show that this complex is recruited to the promoters of certain retinoic-acid-responsive genes, including NPM itself. Such binding of AP2alpha, and consequent recruitment of NPM, is selective and dependent on a consensus AP2alpha-binding sequence. Remarkably, suppression of NPM by RNA interference alleviates the repression of gene expression mediated by retinoic acid and AP2alpha. Our findings further show that, on promoter binding, NPM probably exerts its repressive effect by inducing a change in local chromatin structure that also engages histone deacetylases. This study unveils a hitherto unrecognized transcriptional corepressor function of the NPM protein, and highlights a novel mechanism by which NPM regulates cell growth and differentiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17318229      PMCID: PMC1852768          DOI: 10.1038/sj.embor.7400909

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  21 in total

1.  CTCF tethers an insulator to subnuclear sites, suggesting shared insulator mechanisms across species.

Authors:  Timur M Yusufzai; Hideaki Tagami; Yoshihiro Nakatani; Gary Felsenfeld
Journal:  Mol Cell       Date:  2004-01-30       Impact factor: 17.970

2.  Analysis of the DNA-binding and activation properties of the human transcription factor AP-2.

Authors:  T Williams; R Tjian
Journal:  Genes Dev       Date:  1991-04       Impact factor: 11.361

Review 3.  Nucleophosmin: a versatile molecule associated with hematological malignancies.

Authors:  Tomoki Naoe; Tatsuya Suzuki; Hitoshi Kiyoi; Takeshi Urano
Journal:  Cancer Sci       Date:  2006-10       Impact factor: 6.716

4.  The t(5;17) acute promyelocytic leukemia fusion protein NPM-RAR interacts with co-repressor and co-activator proteins and exhibits both positive and negative transcriptional properties.

Authors:  R L Redner; J D Chen; E A Rush; H Li; S L Pollock
Journal:  Blood       Date:  2000-04-15       Impact factor: 22.113

5.  Characterization of nucleophosmin (B23) as a Myc target by scanning chromatin immunoprecipitation.

Authors:  K I Zeller; T J Haggerty; J F Barrett; Q Guo; D R Wonsey; C V Dang
Journal:  J Biol Chem       Date:  2001-10-16       Impact factor: 5.157

6.  Identification of nucleophosmin as an NF-kappaB co-activator for the induction of the human SOD2 gene.

Authors:  Sanjit K Dhar; Bert C Lynn; Chotiros Daosukho; Daret K St Clair
Journal:  J Biol Chem       Date:  2004-04-15       Impact factor: 5.157

7.  Comparison of the gene expression profiles of monocytic versus granulocytic lineages of HL-60 leukemia cell differentiation by DNA microarray analysis.

Authors:  Ju Han Song; Jong Man Kim; Seung Hyun Kim; Hyeoung Joon Kim; Jae Jung Lee; Myung Hui Sung; Seung Yong Hwang; Tae Sung Kim
Journal:  Life Sci       Date:  2003-08-15       Impact factor: 5.037

8.  Molecular cloning and characterization of AP-2 epsilon, a fifth member of the AP-2 family.

Authors:  Ramakumar Tummala; Rose-Anne Romano; Elaine Fuchs; Satrajit Sinha
Journal:  Gene       Date:  2003-12-04       Impact factor: 3.688

9.  The RNA binding activity of a ribosome biogenesis factor, nucleophosmin/B23, is modulated by phosphorylation with a cell cycle-dependent kinase and by association with its subtype.

Authors:  Mitsuru Okuwaki; Masafumi Tsujimoto; Kyosuke Nagata
Journal:  Mol Biol Cell       Date:  2002-06       Impact factor: 4.138

10.  Regulation of transcription factor AP-2 by the morphogen retinoic acid and by second messengers.

Authors:  B Lüscher; P J Mitchell; T Williams; R Tjian
Journal:  Genes Dev       Date:  1989-10       Impact factor: 11.361

View more
  30 in total

1.  Activator protein 2 alpha (AP2alpha) suppresses 42 kDa C/CAAT enhancer binding protein alpha (p42(C/EBPalpha)) in head and neck squamous cell carcinoma.

Authors:  Kristi L Bennett; Todd Romigh; Khelifa Arab; Rosemary E Teresi; Yasuhiro Tada; Charis Eng; Christoph Plass
Journal:  Int J Cancer       Date:  2009-03-15       Impact factor: 7.396

Review 2.  Insights into the regulation of neuronal viability by nucleophosmin/B23.

Authors:  Jason A Pfister; Santosh R D'Mello
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-22

3.  Regulation of E2F1-induced apoptosis by the nucleolar protein RRP1B.

Authors:  Jason C Paik; Bing Wang; Kang Liu; Jerry K Lue; Weei-Chin Lin
Journal:  J Biol Chem       Date:  2009-12-29       Impact factor: 5.157

4.  Epigenetic CRISPR Screens Identify Npm1 as a Therapeutic Vulnerability in Non-Small Cell Lung Cancer.

Authors:  Fei Li; Wai-Lung Ng; Troy A Luster; Hai Hu; Vladislav O Sviderskiy; Catríona M Dowling; Kate E R Hollinshead; Paula Zouitine; Hua Zhang; Qingyuan Huang; Michela Ranieri; Wei Wang; Zhaoyuan Fang; Ting Chen; Jiehui Deng; Kai Zhao; Hon-Cheong So; Alireza Khodadadi-Jamayran; Mousheng Xu; Angeliki Karatza; Val Pyon; Shuai Li; Yuanwang Pan; Kristen Labbe; Christina Almonte; John T Poirier; George Miller; Richard Possemato; Jun Qi; Kwok-Kin Wong
Journal:  Cancer Res       Date:  2020-07-09       Impact factor: 12.701

5.  Inhibition of neural crest formation by Kctd15 involves regulation of transcription factor AP-2.

Authors:  Valeria E Zarelli; Igor B Dawid
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

6.  Mutations in the SOD2 promoter reveal a molecular basis for an activating protein 2-dependent dysregulation of manganese superoxide dismutase expression in cancer cells.

Authors:  Yong Xu; Fang Fang; Sanjit K Dhar; Antonio Bosch; William H St Clair; Edward J Kasarskis; Daret K St Clair
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

7.  Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B.

Authors:  Richard F Schlenk; Konstanze Döhner; Michael Kneba; Katharina Götze; Frank Hartmann; Francesco Del Valle; Heinz Kirchen; Elisabeth Koller; Jörg T Fischer; Lars Bullinger; Marianne Habdank; Daniela Späth; Silja Groner; Bernhard Krebs; Sabine Kayser; Andrea Corbacioglu; Andreas Anhalt; Axel Benner; Stefan Fröhling; Hartmut Döhner
Journal:  Haematologica       Date:  2008-12-04       Impact factor: 9.941

8.  Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.

Authors:  Grzegorz Sarek; Annika Järviluoma; Henna M Moore; Sari Tojkander; Salla Vartia; Peter Biberfeld; Marikki Laiho; Päivi M Ojala
Journal:  PLoS Pathog       Date:  2010-03-19       Impact factor: 6.823

9.  NPM1/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling.

Authors:  Mikael S Lindström
Journal:  Biochem Res Int       Date:  2010-10-05

10.  AP-2alpha induces epigenetic silencing of tumor suppressive genes and microsatellite instability in head and neck squamous cell carcinoma.

Authors:  Kristi L Bennett; Todd Romigh; Charis Eng
Journal:  PLoS One       Date:  2009-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.